UNC2025, a small-molecule inhibitor of the MERTK/FLT3 pathway, has demonstrated important antitumor activity against acute lymphoblastic leukemia and acute myeloid leukemia [49,50]. The gene discussed is MERTK; the disease is acute myeloid leukemia.